Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Martí Mascaró-Pol, Ramón Díez-Feijoo, Juan Jose Rodriguez-Sevilla, Concepción Fernández-Rodriguez, Francesc García-Pallarols, Solange Flores, Ivonne Vazquez, Saray Rodriguez-Lopez, David Roman, Eva Gimeno, Luis Colomo, Jose Maiques, Blanca Sánchez-González & Antonio Salar. (2021) Evaluation of routine CT scans in the follow-up of diffuse large B-cell lymphomas. Hematology 26:1, pages 709-715.
Read now
Read now
Junshik Hong, Ji Hyun Kim, Kyoung Hwa Lee, Hee Kyung Ahn, Sanghui Park, Sun Jin Sym, Jinny Park, Eun Kyung Cho, Dong Bok Shin & Jae Hoon Lee. (2014) Symptom-oriented clinical detection versus routine imaging as a monitoring policy of relapse in patients with diffuse large B-cell lymphoma. Leukemia & Lymphoma 55:10, pages 2312-2318.
Read now
Read now
Chan Y. Cheah & John F. Seymour. (2014) Adding weight to a sinking ship: more reasons not to perform routine surveillance imaging in patients with diffuse large B-cell lymphoma in remission. Leukemia & Lymphoma 55:10, pages 2223-2225.
Read now
Read now
Martin Hutchings & Aaron Polliack. (2012) When and how to perform surveillance imaging in patients with lymphoma, and is it worth it?. Leukemia & Lymphoma 53:6, pages 1015-1016.
Read now
Read now
Gregory A. Abel, Ann Vanderplas, Maria A. Rodriguez, Allison L. Crosby, Myron S. Czuczman, Joyce C. Niland, Leo I. Gordon, Michael Millenson, Andrew D. Zelenetz, Jonathan W. Friedberg & Ann S. LaCasce. (2012) High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national database. Leukemia & Lymphoma 53:6, pages 1113-1116.
Read now
Read now
Martin Hutchings. (2011) Routine follow-up scanning of patients with lymphoma: who, when, how, and why?. Leukemia & Lymphoma 52:4, pages 552-553.
Read now
Read now
Tarec El-Galaly, Vineet Prakash, Ilse Christiansen, Jakob Madsen, Preben Johansen, Martin Boegsted, Hans-Erik Johnsen & Anne Bukh. (2011) Efficacy of routine surveillance with positron emission tomography/computed tomography in aggressive non-Hodgkin lymphoma in complete remission: status in a single center. Leukemia & Lymphoma 52:4, pages 597-603.
Read now
Read now
Mariano Provencio, Clara Salas, Isabel Millán, Blanca Cantos, Antonio Sánchez & Carmen Bellas. (2010) Late relapses in Hodgkin lymphoma: a clinical and immunohistochemistry study. Leukemia & Lymphoma 51:9, pages 1-6.
Read now
Read now
Articles from other publishers (58)
Alexandra Rezazadeh, Julie Pruett, Amy Detzner, Natasha Edwin, Mehdi Hamadani, Nirav N. Shah & Timothy S. Fenske. (2023) Immunoglobulin high throughput sequencing (Ig-HTS) minimal residual disease (MRD) analysis is an effective surveillance tool in patients with mantle cell lymphoma. Clinical Lymphoma Myeloma and Leukemia.
Crossref
Crossref
Mariana Bastos Oreiro, Reyes Martín, Pilar Gomez, Nieves López Muñoz, Antonia Rodriguez, Marta Liébana, Belén Navarro, Blanca Sánchez-González, Pilar Marí, Jaime Pérez de Oteiza, Antonio Gutiérrez, Leyre Bento, Eva Domingo Doménech, María Vidal, Raquel Del Campo, Elena Pérez Ceballos, María Infante, Alicia Roldán, Daniel García Belmonte, Miriam Santero, Anna Sureda & Ramón Sanz. (2021) SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment. Cancers 13:10, pages 2412.
Crossref
Crossref
Kenneth Ofori, Govind Bhagat & Alex J. Rai. (2020) Exosomes and extracellular vesicles as liquid biopsy biomarkers in diffuse large B‐cell lymphoma: Current state of the art and unmet clinical needs. British Journal of Clinical Pharmacology 87:2, pages 284-294.
Crossref
Crossref
Urshila Durani, Dennis Asante, Herbert C. Heien, Carrie A. Thompson, Thorvardur Halfdanarson, Lindsey Sangaralingham, Prema Peethambaram, Fernando J. Quevedo, Jose C. Villasboas & Ronald S. Go. (2020) Changes in Frequency of Surveillance Imaging of Survivors of Diffuse Large B-Cell Lymphoma After the American Society of Hematology Choosing Wisely Recommendations. JCO Oncology Practice, pages OP.20.00362.
Crossref
Crossref
Takanori Fukuta, Noriko Nishimura, Yuko Shirouchi, Norihito Inoue, Hideki Uryu, Yoshiharu Kusano, Yuko Mishima, Masahiro Yokoyama, Naoko Tsuyama, Kengo Takeuchi & Yasuhito Terui. (2020) Insignificance of surveillance imaging in patients with diffuse large B-cell lymphoma who achieved first complete remission: a retrospective cohort study. International Journal of Hematology 111:4, pages 567-573.
Crossref
Crossref
Martijn V. Verhagen, Kieran McHugh & Stephan D. Voss. 2019. Imaging in Pediatric Oncology. Imaging in Pediatric Oncology
387
403
.
Vivek Kumar, Sarvadaman Makardhwaj Shrivastava, Trishala Meghal & Binod Abhinav Chandra. 2018. Hematology - Latest Research and Clinical Advances. Hematology - Latest Research and Clinical Advances.
Ka-Won Kang, Se Ryeon Lee, Dae Sik Kim, Eun Sang Yu, Hwa Jung Sung, Seok Jin Kim, Chul Won Choi, Yong Park & Byung Soo Kim. (2018) Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma. PLOS ONE 13:2, pages e0192656.
Crossref
Crossref
Kathrin Vollmer & Christoph Mamot. (2018) Nachsorge beim diffusen grosszelligen B-Zell-Lymphom – Evidenz und Empfehlung. Praxis 107:1, pages 31-34.
Crossref
Crossref
Matthew C. Cheung, Nicole Mittmann, Craig C. Earle, Farah Rahman, Ning Liu & Simron Singh. (2018) Are We Choosing Wisely in Lymphoma? Excessive Use of Surveillance CT Imaging in Patients With Diffuse Large B-cell Lymphoma (DLBCL) in Long-term Remission. Clinical Lymphoma Myeloma and Leukemia 18:1, pages e27-e34.
Crossref
Crossref
Susan M. Hiniker & Richard T. Hoppe. (2017) Post-treatment surveillance imaging in lymphoma. Seminars in Oncology 44:5, pages 310-322.
Crossref
Crossref
Derya ?zy?r?k, Suna Emir, Hac? Ahmet Demir, G?l?ah Bayram Kaba?am & Bahattin Tun?. (2016) Total estimated effective doses from radiologic imaging modalities of children with cancer: a single center experience. World Journal of Pediatrics 13:3, pages 242-247.
Crossref
Crossref
Jonathon B. Cohen, Madhusmita Behera, Carrie A. Thompson & Christopher R. Flowers. (2017) Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma. Blood 129:5, pages 561-564.
Crossref
Crossref
Tycel Phillips & Jessica Mercer. (2017) Surveillance Scans in Lymphoma: Friend or Foe?. Current Treatment Options in Oncology 18:2.
Crossref
Crossref
Luc?a Gra?a, Alfonso Calzado, Paula Hern?ndez & Ricardo Rodr?guez. (2016) Role of computed tomography on large B-cell non-Hodgkin?s lymphoma follow-up and the risk of radiation-induced neoplasm: A retrospective cohort study. European Journal of Radiology 85:3, pages 673-679.
Crossref
Crossref
Tiffany Tang, Zhengming Chen, Pannee Praditsuktavorn, Lay Poh Khoo, Jia Ruan, Soon Thye Lim, Daryl Tan, Colin Phipps, Yuh Shan Lee, Yeow Tee Goh, William Hwang, Miriam Tao, Richard Quek, Mohamad Farid, Richard R. Furman, John P. Leonard & Peter Martin. (2016) Role of Surveillance Imaging in Patients With Peripheral T-Cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 16:3, pages 117-121.
Crossref
Crossref
Tarec Christoffer El-GalalyLasse Hjort JakobsenMartin HutchingsPeter de Nully BrownHerman Nilsson-EhleElisabeth SzékelyKaren Juul MylamViktoria HjalmarHans Erik JohnsenMartin BøgstedMats Jerkeman. (2015) Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish–Swedish Population-Based Study. Journal of Clinical Oncology 33:34, pages 3993-3998.
Crossref
Crossref
Martin Hutchings & Sally Barrington. (2015) FDG-PET for the early treatment monitoring, for final response and follow-up evaluation in lymphoma. Clinical and Translational Imaging 3:4, pages 271-281.
Crossref
Crossref
Sheng-Hsuan Chien, Chia-Jen Liu, Yu-Wen Hu, Ying-Chung Hong, Chung-Jen Teng, Chiu-Mei Yeh, Tzeon-Jye Chiou, Jyh-Pyng Gau & Cheng-Hwai Tzeng. (2015) Frequency of surveillance computed tomography in non-Hodgkin lymphoma and the risk of secondary primary malignancies: A nationwide population-based study. International Journal of Cancer 137:3, pages 658-665.
Crossref
Crossref
Gregory A. Abel. (2015) Does Surveillance Imaging After Treatment for Diffuse Large B-Cell Lymphoma Really Work?. Journal of Clinical Oncology 33:13, pages 1427-1429.
Crossref
Crossref
Patrick M. Vos, Stuart A. Barnard & Peter L. Cooperberg. 2015. Textbook of Gastrointestinal Radiology, 2-Volume Set. Textbook of Gastrointestinal Radiology, 2-Volume Set
1923
1964
.
Tarec Christoffer El-Galaly & Martin Hutchings. 2015. Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma
125
146
.
Jonathon B. Cohen & Christopher R. Flowers. (2014) Optimal disease surveillance strategies in non-Hodgkin lymphoma. Hematology 2014:1, pages 481-487.
Crossref
Crossref
Carrie A. ThompsonHerve GhesquieresMatthew J. MaurerJames R. CerhanPierre BironStephen M. AnsellCatherine Chassagne-ClémentDavid J. InwardsThérèse GargiPatrick B. JohnstonEmmanuelle Nicolas-VirelizierWilliam R. MaconMarie PeixIvana N. MicallefCatherine SebbanGrzegorz S. NowakowskiLuis F. PorrataGeorge J. WeinerThomas E. WitzigThomas M. HabermannBrian K. Link. (2014) Utility of Routine Post-Therapy Surveillance Imaging in Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology 32:31, pages 3506-3512.
Crossref
Crossref
Karen Juul Mylam, Anne Lerberg Nielsen, Lars Møller Pedersen & Martin Hutchings. (2014) Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Diffuse Large B-cell Lymphoma. PET Clinics 9:4, pages 443-455.
Crossref
Crossref
Chan Y. Cheah, Michael Dickinson, Michael S. Hofman, Anupkumar George, David S. Ritchie, H. Miles Prince, David Westerman, Simon J. Harrison, Kate Burbury, Max Wolf, Henry Januszewicz, Kirsten E. Herbert, Dennis A. Carney, Constantine Tam & John F. Seymour. (2014) Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy. Annals of Hematology 93:7, pages 1193-1200.
Crossref
Crossref
TC El-Galaly, Karen Juul Mylam, Martin Bøgsted, Peter Brown, Maria Rossing, Anne Ortved Gang, Anne Haglund, Bente Arboe, Michael Roost Clausen, Paw Jensen, Michael Pedersen, Anne Bukh, Bo Amdi Jensen, Christian Bjørn Poulsen, Francesco d'Amore & Martin Hutchings. (2014) Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma. American Journal of Hematology 89:6, pages 575-580.
Crossref
Crossref
Ryan C. LynchAndrew D. ZelenetzJames O. ArmitageKenneth R. Carson. (2014) Surveillance Imaging for Lymphoma: Pros and Cons. American Society of Clinical Oncology Educational Book:34, pages e388-e395.
Crossref
Crossref
Quoc Truong, Nilay Shah, Mark Knestrick, Brendan Curley, Yanqing Hu, Michael Craig & Mehdi Hamadani. (2014) Limited Utility of Surveillance Imaging for Detecting Disease Relapse in Patients With Non-Hodgkin Lymphoma in First Complete Remission. Clinical Lymphoma Myeloma and Leukemia 14:1, pages 50-55.
Crossref
Crossref
É. Herin, J. Chalaye, J.-L. Lagrange, K. Belhadj, É. De Kerviler, A. Luciani, A. Rahmouni & E. Itti. 2014. Imagerie Post-Thérapeutique en Oncologie. Imagerie Post-Thérapeutique en Oncologie
265
298
.
Kieran McHugh & Derek J. Roebuck. (2014) Pediatric oncology surveillance imaging: Two recommendations. Abandon CT scanning, and randomize to imaging or solely clinical follow-up. Pediatric Blood & Cancer 61:1, pages 3-6.
Crossref
Crossref
Lisa K. HicksHarriet BeringKenneth R. CarsonJudith KleinermanVishal KukretiAlice MaBrigitta U. MuellerSarah H. O'BrienMarcelo PasquiniRavindra SarodeLawrence SolbergJrJrAdam E. Haynes & Mark A. Crowther. (2013) The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. Hematology 2013:1, pages 9-14.
Crossref
Crossref
Lisa K. HicksHarriet BeringKenneth R. CarsonJudith KleinermanVishal KukretiAlice MaBrigitta U. MuellerSarah H. O'BrienMarcelo PasquiniRavindra SarodeLawrence SolbergJrJrAdam E. Haynes & Mark A. Crowther. (2013) The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. Blood 122:24, pages 3879-3883.
Crossref
Crossref
C Y Cheah, M S Hofman, M Dickinson, A Wirth, D Westerman, S J Harrison, K Burbury, M Wolf, H Januszewicz, K Herbert, H M Prince, D A Carney, D S Ritchie, R J Hicks & J F Seymour. (2013) Limited role for surveillance PET–CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy. British Journal of Cancer 109:2, pages 312-317.
Crossref
Crossref
Ayman I. Kamel, Tamer F. Taha Ali & Mohamed A. Tawab. (2013) Potential impact of PET/CT on the initial staging of lymphoma. The Egyptian Journal of Radiology and Nuclear Medicine 44:2, pages 331-338.
Crossref
Crossref
Irit Avivi, Ariel Zilberlicht, Eldad J. Dann, Ronit Leiba, Tal Faibish, Jacob M. Rowe & Rachel Bar‐Shalom. (2013) Strikingly high false positivity of surveillance FDG‐PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era. American Journal of Hematology 88:5, pages 400-405.
Crossref
Crossref
Junshik Hong, Hyun-Hwa Yoon, Hee Kyung Ahn, Sun Jin Sym, Jinny Park, Pil-Whan Park, Jeong Yeal Ahn, Sanghui Park, Eun Kyung Cho, Dong Bok Shin & Jae Hoon Lee. (2013) Prognostic Role of Serum Lactate Dehydrogenase Beyond Initial Diagnosis: A Retrospective Analysis of Patients with Diffuse Large B Cell Lymphoma. Acta Haematologica 130:4, pages 305-311.
Crossref
Crossref
Tung-Liang Lin, Ming-Chung Kuo, Lee-Yung Shih, Po Dunn, Po-Nan Wang, Jin-Hou Wu, Tzung-Chih Tang, Hung Chang, Yu-Shin Hung & Shu-Chen Lu. (2012) Value of surveillance computed tomography in the follow-up of diffuse large B-cell and follicular lymphomas. Annals of Hematology 91:11, pages 1741-1745.
Crossref
Crossref
A.M. Garc?a Vicente, M. Bell?n Guardia, A. Soriano Castrej?n, C. Calle Primo, J.M. Cordero Garc?a, A. Palomar Mu?oz, J.P. Pilkington Woll, M.P. Talavera Rubio & B. Hern?ndez Ruiz. (2012) 18F-FDG-PET/CT in the surveillance of patients with lymphoma: Detection of asymptomatic recurrences. Revista Espa?ola de Medicina Nuclear e Imagen Molecular (English Edition) 31:1, pages 22-27.
Crossref
Crossref
A.M. Garc?a Vicente, M. Bell?n Guardia, A. Soriano Castrej?n, C. Calle Primo, J.M. Cordero Garc?a, A. Palomar Mu?oz, J.P. Pilkington Woll, M.P. Talavera Rubio & B. Hern?ndez Ruiz. (2012) PET-TAC con 18F-FDG en el seguimiento de pacientes con linfoma: detecci?n de recidivas asintom?ticas. Revista Espa?ola de Medicina Nuclear e Imagen Molecular 31:1, pages 22-27.
Crossref
Crossref
Jakub Svoboda & Stephen J. Schuster. (2012) The Evolving Role of Medical Imaging in Lymphoma Management: The Clinician’s Perspective. PET Clinics 7:1, pages 35-46.
Crossref
Crossref
Sue C. Kaste. (2011) Oncological imaging: tumor surveillance in children. Pediatric Radiology 41:S2, pages 505-508.
Crossref
Crossref
Neta Goldschmidt, Omer Or, Martine Klein, Bella Savitsky & Ora Paltiel. (2010) The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma. Annals of Hematology 90:2, pages 165-171.
Crossref
Crossref
Giovanni MartinelliShu-Fang Hsu SchmitzUrs UtigerThomas CernyUrs HessSimona BassiEmmie OkkingaRoger StuppRolf StahelMarc HeizmannDaniel VorobiofAndreas LohriPierre-Yves DietrichEmanuele ZuccaMichele Ghielmini. (2010) Long-Term Follow-Up of Patients With Follicular Lymphoma Receiving Single-Agent Rituximab at Two Different Schedules in Trial SAKK 35/98. Journal of Clinical Oncology 28:29, pages 4480-4484.
Crossref
Crossref
Amy Lee Chong, Ronald M. Grant, Bilal A. Ahmed, Karen E. Thomas, Bairbre L. Connolly & Mark Greenberg. (2010) Imaging in pediatric patients: Time to think again about surveillance. Pediatric Blood & Cancer 55:3, pages 407-413.
Crossref
Crossref
Pareen Shenoy, Rajni Sinha, John W. Tumeh, Mary Jo Lechowicz & Christopher Flowers. (2010) Surveillance Computed Tomography Scans for Patients With Lymphoma: Is the Risk Worth the Benefits?. Clinical Lymphoma Myeloma and Leukemia 10:4, pages 270-277.
Crossref
Crossref
. 2010. High-Yield Imaging: Gastrointestinal. High-Yield Imaging: Gastrointestinal
741
743
.
Michal Weiler-Sagie & Ora Israel. 2010. Hybrid PET/CT and SPECT/CT Imaging. Hybrid PET/CT and SPECT/CT Imaging
513
554
.
Patrick M. Vos, Stuart A. Barnard & Peter L. Cooperberg. 2008. Textbook of Gastrointestinal Radiology. Textbook of Gastrointestinal Radiology
2005
2049
.
Philippe Debourdeau, Michel Pavic, Christine Zammit, Marc Aletti, Corinne Pogant & Bernard Colle. (2007) Surveillance des cancers en rémission complète. La Presse Médicale 36:6, pages 949-963.
Crossref
Crossref
L. Huang, M. Lequin, R. Pieters & M.M. van den Heuvel‐Eibrink. (2007) The clinical value of follow‐up examinations in childhood T‐cell acute lymphoblastic leukemia and T‐cell non‐Hodgkin's lymphoma. Pediatric Blood & Cancer 48:4, pages 468-472.
Crossref
Crossref
Christian la Fougère, Walter Hundt, Nicole Bröckel, Thomas Pfluger, Alexander Haug, Bernhard Scher, Marcus Hacker, Klaus Hahn, Maximilan Reiser & Reinhold Tiling. (2006) Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin’s disease and non-Hodgkin’s lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 33:12, pages 1417-1425.
Crossref
Crossref
J.O. Armitage & F.R. Loberiza. (2006) Is there a place for routine imaging for patients in complete remission from aggressive lymphoma?. Annals of Oncology 17:6, pages 883-884.
Crossref
Crossref
M. Liedtke, P.A. Hamlin, C.H. Moskowitz & A.D. Zelenetz. (2006) Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population. Annals of Oncology 17:6, pages 909-913.
Crossref
Crossref
A Schwartz, M K Gospodarowicz, K Khalili, M Pintilie, S Goddard, A Keller & R W Tsang. (2006) An audit of imaging test utilization for the management of lymphoma in an oncology hospital: implications for resource planning?. The British Journal of Radiology 79:938, pages 116-122.
Crossref
Crossref
Simona Biasotti, Alberto Garaventa, Paola Padovani, Maura Faraci, Francesca Fioredda, Guia Hanau, Francesca Grisolia, Stefano Parodi & Riccardo Haupt. (2005) Role of active follow-up for early diagnosis of relapse after elective end of therapies. Pediatric Blood & Cancer 45:6, pages 781-786.
Crossref
Crossref
M.J. Reinhardt, C. Herkel, C. Altehoefer, J. Finke & E. Moser. (2005) Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients: when do we really need FDG-PET?. Annals of Oncology 16:9, pages 1524-1529.
Crossref
Crossref
Nat Lenzo. (2004) The Australian Government's Review of Positron Emission Tomography: evidence‐based policy decision‐making in action. Medical Journal of Australia 181:9, pages 516-517.
Crossref
Crossref